UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)

Journal of clinical oncology, 2024-01, Vol.42 (2), p.170-179

2024

Volltextzugriff (PDF)

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: Taking Endometrial Cancer Trials Into the Translational Era

International journal of gynecological cancer, 2013-10, Vol.23 (8), p.1528-1534

2013

Volltextzugriff (PDF)

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4349-4350

2020

Volltextzugriff (PDF)

Bringing PROMIS to practice: Brief and precise symptom screening in ambulatory cancer care

Cancer, 2015-03, Vol.121 (6), p.927-934

2015

Volltextzugriff (PDF)

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2011-03, Vol.29 (7), p.825-831

2011

Volltextzugriff (PDF)

Malignant melanoma of the vulva: An extension of cutaneous melanoma?

Gynecologic oncology, 2011-09, Vol.122 (3), p.612-617

2011

Volltextzugriff (PDF)

Tumor suppression by control of matrix metalloproteinase recycling

Molecular & cellular oncology, 2019-11, Vol.6 (6), p.e1646606-e1646606

2019

Volltextzugriff (PDF)

15 years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

Gynecologic oncology, 2017-01

2017

Volltextzugriff (PDF)

Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial

BMC cancer, 2018-09, Vol.18 (1), p.886-17, Article 886

2018

Volltextzugriff (PDF)

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

Gynecologic oncology, 2020-08, Vol.158 (2), p.354-360

2020

Volltextzugriff (PDF)

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

Journal of clinical oncology, 2024-07, Vol.42 (20), p.2425-2435

2024

Volltextzugriff (PDF)

Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy

Gynecologic oncology, 2012-06, Vol.125 (3), p.572-575

2012

Volltextzugriff (PDF)

Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978

Gynecologic oncology, 2015-08, Vol.138 (2), p.339-342

2015

Volltextzugriff (PDF)

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors

Gynecologic oncology, 2011-05, Vol.121 (2), p.285-289

2011

Volltextzugriff (PDF)

Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53

Gynecologic oncology, 2004-06, Vol.93 (3), p.575-585

2004

Volltextzugriff (PDF)

Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research

Journal of experimental & clinical cancer research, 2009-06, Vol.28 (1), p.79-79, Article 79

2009

Volltextzugriff (PDF)

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence—the University of Wisconsin experience

International journal of radiation oncology, biology, physics, 1999-12, Vol.45 (5), p.1267-1274

1999

Volltextzugriff (PDF)

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

Gynecologic oncology, 2013-11, Vol.131 (2), p.362-367

2013

Volltextzugriff (PDF)

Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy

Cancer, 2008-08, Vol.113 (4), p.861-869

2008

Volltextzugriff (PDF)

Robotic surgery in gynecologic oncology: Impact on fellowship training

Gynecologic oncology, 2009-08, Vol.114 (2), p.168-172

2009

Volltextzugriff (PDF)

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer

Journal of Gynecologic Oncology, 2013, 24(3), , pp.258-264

2013

Volltextzugriff (PDF)

Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy

NPJ breast cancer, 2019-04, Vol.5 (1), p.13-13, Article 13

2019

Volltextzugriff (PDF)

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers

JNCI : Journal of the National Cancer Institute, 2014-10, Vol.106 (10), p.1

2014

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(71)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(67)
Science & Technology
(67)
Humans
(60)
Female
(55)
Middle Aged
(34)
Adult
(29)
Aged
(29)
Obstetrics & Gynecology
(27)
Neoplasm Staging
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Ovarian Neoplasms - Drug Therapy
(16)
Treatment Outcome
(16)
Chemotherapy
(15)
Obstetrics And Gynecology
(15)
Aged, 80 And Over
(14)
Hematology, Oncology And Palliative Medicine
(14)
Tumors
(14)
Retrospective Studies
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: Taking Endometrial Cancer Trials Into the Translational Era

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

Bringing PROMIS to practice: Brief and precise symptom screening in ambulatory cancer care

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

Malignant melanoma of the vulva: An extension of cutaneous melanoma?

Tumor suppression by control of matrix metalloproteinase recycling

15 years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy

Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors

Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53

Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence—the University of Wisconsin experience

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy

Robotic surgery in gynecologic oncology: Impact on fellowship training

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer

Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy

Synuclein‐γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers

Aktive Filter

Suchergebnisse filtern